OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
REG58

Regis Healthcare Ltd

Healthcare Facilities & ServicesVerified

Regis Healthcare Ltd has a negative equity position of -16.72 million AUD, indicating a significant financial challenge in its capital structure. The company's liquidity is further constrained by a current ratio of 0.11, suggesting that it may struggle to meet short-term obligations with its current assets. Despite this, the company reported an operating cash flow of 306.11 million AUD, which is a positive sign of operational efficiency. However, the free cash flow is negative at -32.07 million AUD, indicating that the company is spending more on capital expenditures than it is generating in cash. In terms of profitability, the company's return on assets is 2.33%, which is relatively low and suggests that the company is not effectively utilizing its assets to generate profit. The return on equity is negative at -292.7%, indicating that the company is not generating returns for its shareholders and is, in fact, losing value. These metrics are below the industry median for healthcare facilities and services, highlighting a need for operational improvements. The company's revenue is primarily concentrated in its core healthcare services, with no significant diversification across segments or geographic regions disclosed in the available data. This lack of diversification could pose a risk if the company's primary market experiences a downturn. The company's growth trajectory is also uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting potential liquidity constraints. The dilution risk is low, which is a positive aspect for shareholders, as it indicates that the company is not likely to issue additional shares that could dilute existing ownership. Recent events and filings have not been disclosed in the available data, so there is no information on specific recent developments that could impact the company's operations or financial position. The company's financial health and strategic direction will need to be closely monitored to assess its ability to navigate potential challenges and capitalize on opportunities in the healthcare sector.

30-day price · REG+0.09 (+1.5%)
Low$5.62High$7.05Close$6.19As of16 May, 00:00 UTC
Profile
CompanyRegis Healthcare Ltd
TickerREG.AX
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Regis Healthcare Ltd operates in the healthcare facilities and services industry, providing pharmaceutical and healthcare services to patients and healthcare providers.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Regis Healthcare Ltd has a negative equity position of -16.72 million AUD, indicating a significant financial challenge in its capital structure. The company's liquidity is further constrained by a current ratio of 0.11, suggesting that it may struggle to meet short-term obligations with its current assets. Despite this, the company reported an operating cash flow of 306.11 million AUD, which is a positive sign of operational efficiency. However, the free cash flow is negative at -32.07 million AUD, indicating that the company is spending more on capital expenditures than it is generating in cash. In terms of profitability, the company's return on assets is 2.33%, which is relatively low and suggests that the company is not effectively utilizing its assets to generate profit. The return on equity is negative at -292.7%, indicating that the company is not generating returns for its shareholders and is, in fact, losing value. These metrics are below the industry median for healthcare facilities and services, highlighting a need for operational improvements. The company's revenue is primarily concentrated in its core healthcare services, with no significant diversification across segments or geographic regions disclosed in the available data. This lack of diversification could pose a risk if the company's primary market experiences a downturn. The company's growth trajectory is also uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting potential liquidity constraints. The dilution risk is low, which is a positive aspect for shareholders, as it indicates that the company is not likely to issue additional shares that could dilute existing ownership. Recent events and filings have not been disclosed in the available data, so there is no information on specific recent developments that could impact the company's operations or financial position. The company's financial health and strategic direction will need to be closely monitored to assess its ability to navigate potential challenges and capitalize on opportunities in the healthcare sector.
Key takeaways
  • Regis Healthcare Ltd has a negative equity position, indicating a significant financial challenge.
  • The company's liquidity is constrained, with a current ratio of 0.11 and a negative free cash flow.
  • The company's return on equity is negative, suggesting that it is not generating returns for its shareholders.
  • The company's revenue is primarily concentrated in its core healthcare services, with no significant diversification.
  • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
  • The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$1.16B
Gross profit
Operating income$60.0M
Net income$49.0M
R&D
SG&A
D&A
SBC
Operating cash flow$306.1M
CapEx-$86.5M
Free cash flow-$32.1M
Total assets$2.11B
Total liabilities$2.12B
Total equity-$16.7M
Cash & equivalents
Long-term debt$5.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$16.7M
Net cash-$5.1M
Current ratio0.1
Debt/Equity-0.3
ROA2.3%
ROE-2.9%
Cash conversion6.2%
CapEx/Revenue-7.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 779 companies
MetricREGActivity
Op margin5.2%7.7% medp25 -2.4% · p75 15.5%below median
Net margin4.2%5.9% medp25 -3.8% · p75 12.8%below median
Gross margin45.5% medp25 31.1% · p75 62.9%
R&D / revenue529.2% medp25 465.2% · p75 593.2%
CapEx / revenue-7.4%-7.0% medp25 -14.9% · p75 -3.2%below median
Debt / equity-31.0%25.0% medp25 3.8% · p75 63.3%bottom quartile
Observations
IR observations
Mean price target8.46 AUD
Median price target8.50 AUD
High price target9.00 AUD
Low price target8.00 AUD
Mean recommendation1.80 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count2.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.18 AUD
Last actual EPS0.16 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 00:23 UTC#cab328d6
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 04:32 UTCJob: 6bab33a7